State of Wisconsin Investment Board’s Akcea Therapeutics Inc AKCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-19,400
Closed -$352K 2048
2020
Q3
$352K Sell
19,400
-3,600
-16% -$51.1K ﹤0.01% 1592
2020
Q2
$315K Buy
23,000
+3,600
+19% +$55.5K ﹤0.01% 1545
2020
Q1
$277K Buy
19,400
+1,800
+10% +$29.5K ﹤0.01% 1516
2019
Q4
$298K Hold
17,600
﹤0.01% 1546
2019
Q3
$271K Hold
17,600
﹤0.01% 1466
2019
Q2
$413K Buy
17,600
+400
+2% +$9.88K ﹤0.01% 1372
2019
Q1
$487K Buy
17,200
+4,000
+30% +$117K ﹤0.01% 1353
2018
Q4
$398K Hold
13,200
﹤0.01% 1373
2018
Q3
$462K Buy
+13,200
New +$399K ﹤0.01% 1414

State of Wisconsin Investment Board's AKCA Position: Q4 2020 in Review

State of Wisconsin Investment Board sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 19,400 shares — an estimated $352K sold.

State of Wisconsin Investment Board first reported a position in AKCA in Q3 2018 and held it in 9 quarters. The position peaked at $487K in Q1 2019. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • State of Wisconsin Investment Board reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 19,400 Akcea Therapeutics Inc shares in Q4 2020, an estimated $352K.
  • State of Wisconsin Investment Board first reported a position in Akcea Therapeutics Inc in Q3 2018 and held it in 9 quarters.
  • State of Wisconsin Investment Board's Akcea Therapeutics Inc position peaked at $487K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2020, filed 3 Feb 2021.